Metraipolis › archive › dc_221c10ff541e

Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42132105
DOI
10.1042/bst20250134
License (as archived)
solo-consultazione
Archived
2026-11-02T19:55:11.616Z
SHA-256 of the archived text
41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088
Stable URL of this page
https://metraipolis.com/documento/dc_221c10ff541e

How to cite

Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105 — Europe PMC (en), https://europepmc.org/article/MED/42132105 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_221c10ff541e (Metraipolis archive dc_221c10ff541e, sha256 41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088)
BibTeX
@misc{dc221c10ff541e,
  title = {Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations — Europe PMC PMID:42132105},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42132105},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_221c10ff541e; sha256 41be29c800b0340905733c3cc392a8391b03d2434851213b25d60fe8a4b76088},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42132105. Agents can read the archived copy with the MCP tool read_document.